These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 21908103)

  • 61. Neuromedin B receptor antagonism inhibits migration, invasion, and epithelial-mesenchymal transition of breast cancer cells.
    Park HJ; Kim MK; Choi KS; Jeong JW; Bae SK; Kim HJ; Bae MK
    Int J Oncol; 2016 Sep; 49(3):934-42. PubMed ID: 27571778
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Broad-spectrum G protein-coupled receptor antagonist, [D-Arg1,D-Trp5,7,9,Leu11]SP: a dual inhibitor of growth and angiogenesis in pancreatic cancer.
    Guha S; Eibl G; Kisfalvi K; Fan RS; Burdick M; Reber H; Hines OJ; Strieter R; Rozengurt E
    Cancer Res; 2005 Apr; 65(7):2738-45. PubMed ID: 15805273
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Neuromedin B receptor antagonist suppresses tumor angiogenesis and tumor growth in vitro and in vivo.
    Park HJ; Kim SR; Kim MK; Choi KS; Jang HO; Yun I; Bae SK; Bae MK
    Cancer Lett; 2011 Dec; 312(1):117-27. PubMed ID: 21908103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 4.